ResearcherChulalongkorn UniversityActive in the last 2 years
Thaninee Prasoppokakorn
Matched on ORCID iD 0000-0002-1012-9874; OpenAlex author ID A5039034068. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers
Papers 3
- Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ductal adenocarcinoma. Co-author DOI 10.1055/a-2535-7440↗
- Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ductal adenocarcinoma. Co-author DOI 10.1055/a-2571-2951↗
- Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS: A systematic review and meta-analysis. Co-author DOI 10.4103/eus-d-20-00219↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Pradermchai Kongkam · 3 shared papers, 2022–2025 · strength 0.66
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Paper Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS: A systematic review an… DOI 10.4103/eus-d-20-00219↗
- Rungsun Rerknimitr · 3 shared papers, 2022–2025 · strength 0.66
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Paper Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS: A systematic review an… DOI 10.4103/eus-d-20-00219↗
- Parit Mekaroonkamol · 3 shared papers, 2022–2025 · strength 0.66
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Paper Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS: A systematic review an… DOI 10.4103/eus-d-20-00219↗
- Roongruedee Chaiteerakij · 3 shared papers, 2022–2025 · strength 0.66
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Paper Application of artificial intelligence for diagnosis of pancreatic ductal adenocarcinoma by EUS: A systematic review an… DOI 10.4103/eus-d-20-00219↗
- Phonthep Angsuwatcharakon · 2 shared papers, 2025 · strength 0.49
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Nipan Israsena · 2 shared papers, 2025 · strength 0.49
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.